New York - Even as biologic therapies become available, there will still be a place for acitretin, methotrexate and cyclosporin-based treatment protocols, according to Mark Lebwohl, M.D.
Nearly half of FDA-authorized AI tools may be ineffective
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Preclinical Medical Students Perform Similarly in Evaluating, Diagnosing Dermatological Diseases in Varying Skin Types
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Study Compares Dose Escalation with Biologics in Psoriasis
Isotretinoin’s Role in Rosacea Management